Prevalence of Hyperuricemia and the Use of Allopurinol in Older Poles-Results from a Population-Based PolSenior Study
- PMID: 33419128
- PMCID: PMC7825523
- DOI: 10.3390/ijerph18020387
Prevalence of Hyperuricemia and the Use of Allopurinol in Older Poles-Results from a Population-Based PolSenior Study
Abstract
Background: Our study analyzes the frequency and risk factors of hyperuricemia and the use of allopurinol in a representative cohort of the older Polish adult population.
Methods: The analysis was a part of a cross-sectional PolSenior study on aging in Poland. The complete medication data were available in 4873 out of 4979 community dwelling respondents aged 65 and over. Serum uric acid concentrations were evaluated in 4028 participants (80.9% of the cohort).
Results: Hyperuricemia was observed in 28.2% of women and 24.7% of men. Ten risk factors of hyperuricemia were selected based on multivariable LASSO logistic regression analysis. Nine factors showed significant odds ratios: eGFR < 60 mL/min/1.73 m2 (OR = 4.10), hypertriglyceridemia (OR = 1.88), obesity (OR = 1.75), heart failure (1.70), CRP > 3.0 mg/dL (OR = 1.64), coronary artery disease (OR = 1.30), use of loop-diuretics (OR = 4.20), hydrochlorothiazide (OR = 2.96), and thiazide-like diuretics (OR = 2.81). Allopurinol was used by 2.8% of men and 1.8% of women. The therapy was considered effective in 46.7% of men and 53.3% of women.
Conclusions: Hyperuricemia was present in 23.1% (95% CI: 21.8-24.4) of the older Polish population. The frequency of hyperuricemia increases with age, reaching 30.5% in men and 33.7% in women aged 90 years or more. Chronic kidney disease, obesity, heart failure, hypertriglyceridemia, and the use of diuretics were the strongest risk factors for hyperuricemia in older adults. The treatment with allopurinol was ineffective in more than half of participants.
Keywords: allopurinol; elderly; hyperuricemia; prevalence.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Hyperuricemia in adult renal allograft recipients: prevalence and predictors.Transplant Proc. 2012 Oct;44(8):2369-72. doi: 10.1016/j.transproceed.2012.07.033. Transplant Proc. 2012. PMID: 23026595
-
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly.Eur J Intern Med. 2014 Nov;25(9):847-52. doi: 10.1016/j.ejim.2014.09.019. Epub 2014 Oct 22. Eur J Intern Med. 2014. PMID: 25439099
-
Is rasburicase an effective alternative to allopurinol for management of hyperuricemia in renal failure patients? A double blind-randomized study.Eur Rev Med Pharmacol Sci. 2007 May-Jun;11(3):179-84. Eur Rev Med Pharmacol Sci. 2007. PMID: 17970234 Clinical Trial.
-
The net clinical benefits of febuxostat versus allopurinol in patients with gout or asymptomatic hyperuricemia - A systematic review and meta-analysis.Nutr Metab Cardiovasc Dis. 2019 Oct;29(10):1011-1022. doi: 10.1016/j.numecd.2019.06.016. Epub 2019 Jun 24. Nutr Metab Cardiovasc Dis. 2019. PMID: 31378626
-
The Association of Febuxostat Compared With Allopurinol on Blood Pressure and Major Adverse Cardiac Events Among Adult Patients With Hyperuricemia: A Meta-analysis.J Cardiovasc Pharmacol. 2020 Oct;76(4):461-471. doi: 10.1097/FJC.0000000000000871. J Cardiovasc Pharmacol. 2020. PMID: 32675751
Cited by
-
The correlation between dietary inflammatory index and risk of hyperuricemia in the U.S. population.Medicine (Baltimore). 2023 May 19;102(20):e33374. doi: 10.1097/MD.0000000000033374. Medicine (Baltimore). 2023. PMID: 37335705 Free PMC article.
-
Association of serum uric acid with anemia in U.S. adults: a cross-sectional study using secondary data.BMC Cardiovasc Disord. 2023 Jun 8;23(1):291. doi: 10.1186/s12872-023-03291-y. BMC Cardiovasc Disord. 2023. PMID: 37291524 Free PMC article.
-
Prevalence of Hyperuricemia and Rheumatoid Factor Positivity Among Patients Aged 35 and Above in Huye District, Southern Province of Rwanda.Open Access Rheumatol. 2024 Nov 26;16:147-156. doi: 10.2147/OARRR.S495467. eCollection 2024. Open Access Rheumatol. 2024. PMID: 39618700 Free PMC article.
-
Hyperuricemia-Especially "Metabolic Hyperuricemia"-Is Independently Associated with a Higher Risk of Steatotic Liver Disease.Metabolites. 2025 May 28;15(6):356. doi: 10.3390/metabo15060356. Metabolites. 2025. PMID: 40559381 Free PMC article.
-
Inflammation in Older Poles with Localized and Widespread Chronic Pain-Results from a Population-Based PolSenior Study.J Clin Med. 2024 Oct 1;13(19):5870. doi: 10.3390/jcm13195870. J Clin Med. 2024. PMID: 39407930 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous